Page results
- 
                                    
                                                                            
Proton Beam Therapy (PBT) is a particularly effective form of radiotherapy used to treat certain types of cancers
 - 
                                    
                                                                            
Information about travelling to your appointment for UCLH cancer services and different locations and hospitals.
 - 
                                    
                                                                            
The emergency department at University College Hospital is set to undergo an ambitious refurbishment project of the resuscitation (resus) area.
 - 
                                    
                                                                            
Tens of thousands of people in England who have hepatitis C could now get tested and treated thanks to a new mobile health unit arriving to coincide with World Hepatitis Day on 28 July.
 - 
                                    
                                                                            
An evaluation of temporary changes to children and young people’s services in North Central London (NCL) in the autumn and winter of 2020/21 has been published.
 - 
                                    
                                                                            
A major new consortium led by UCLH and UCL has been awarded £6.8 million by the National Institute of Health Research to conduct the largest clinical study of long COVID over the next two years.
 - 
                                    
                                                                            
In May 2020, UCLH invited acclaimed photographer Tom Pilston to take portraits of staff at the height of the Covid-19 pandemic.
 - 
                                    
                                                                            
Two doses of the Oxford-AstraZeneca COVID-19 vaccine induce lower levels of antibodies that are able to recognise and fight the SARS-CoV-2 Delta variant (B.1.617.2) than against other strains, according to laboratory findings from UCLH and the Francis Crick Institute.
 - 
                                    
                                                                            
Researchers at the NIHR UCLH Clinical Research Facility are the first in the world to start a new first-in-human trial investigating a novel treatment, called NVG-111, in patients with Non-Hodgkin lymphoma (NHL) subtypes.
 - 
                                    
                                                                            
People infected with coronavirus have a distinct odour that can be detected by trained dogs with a high degree of accuracy, according to new research involving UCLH.
 
File results
- 
                                                                            
Council of Governors meeting papers - 31 October
 - 
                                                                            
Consultant - to -consultant referral form
 - 
                                                                            
UCLH Provider to Provider Tariff 2019-20
 - 
                                                                            
What young people would like everyone to know about Type 1 Diabetes
 - 
                                                                            
Reverse mentoring
 - 
                                                                            
FOI/2020/0572 - Inflamatory bowel disease staff contact details
 - 
                                                                            
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
 - 
                                                                            
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
 - 
                                                                            
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
 - 
                                                                            
FOI2017333 Midwifery contacts for accessing return to practice placements